NOX 14.3% 8.0¢ noxopharm limited

Ann: Publications Positive Review of Veyonda in Chemotherapy, page-9

  1. 454 Posts.
    lightbulb Created with Sketch. 66
    it also states that the study was not to prove efficacy, only safety. they went on further to state however, efficacy results look promising. it also must be mentioned that the study was only a very small cohort. much larger is need for a efficacy study to confirm what Dr Kelly and the im sure the reviewers will be expecting.
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
0.010(14.3%)
Mkt cap ! $23.37M
Open High Low Value Volume
7.0¢ 8.0¢ 7.0¢ $4.207K 56.02K

Buyers (Bids)

No. Vol. Price($)
1 118527 7.5¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 4999 1
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.